Home » U.S. GAO Calls for Device Recall Oversight Reform by FDA
U.S. GAO Calls for Device Recall Oversight Reform by FDA
July 1, 2011
The U.S. Food and Drug Administration (FDA) should launch a program to routinely and systematically assess device recall information, and use this program to identify strategies for mitigating health risks presented by defective or unsafe devices, the U.S. Government Accountability Office (GAO) says.
To View This Article:
Subscribe To International Medical Device Regulatory Monitor